Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis

Moser, Christian and Schachtschneider, Philipp and Lang, Sven A. and Gaumann, Andreas and Mori, Akira and Zimmermann, Johann and Schlitt, Hans J. and Geissler, Edward K. and Stoeltzing, Oliver (2008) Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis. EUROPEAN JOURNAL OF CANCER, 44 (11). pp. 1577-1586. ISSN 0959-8049,

Full text not available from this repository. (Request a copy)

Abstract

The insulin-like growth factor-I receptor (IGF-IR) is frequently overexpressed and constitutively activated in pancreatic cancer, thus representing a promising target for therapy. We investigated the impact of a novel inhibitor of IGF-IR (NVP-AEW541) on signalling and growth of pancreatic cancer. Human pancreatic cancer cells and endothelial cells were employed, and effects of NVP-AEW541 on signalling pathways investigated by Western blotting. NVP-AEW541 diminished the activation of IGF-IR, IRS-1, Erk, Akt and STAT3. Furthermore, NVP-AEW541 reduced cancer cell proliferation and abrogated migratory effects of IGF-1. NVP-AEW541 elicited a direct effect on endothelial cells in terms of reducing endothelial cell migration. In vivo, treatment of mice with NVP-AEW541 significantly reduced orthotopic pancreatic tumour growth, vascularisation, and VEGF expression. Interestingly, NVP-AEW541 lowered serum levels of IGF-binding-protein-3 (IGFBP-3). In conclusion, the IGF-IR inhibitor NVP-AEW541 effectively disrupts IGF-I signalling and reduces pancreatic tumour growth. Hence, blocking IGF-IR could prove valuable for targeted therapy of pancreatic cancer. (c) 2008 Elsevier Ltd. All rights reserved.

Item Type: Article
Uncontrolled Keywords: MYELOID-LEUKEMIA CELLS; TUMOR-GROWTH; MONOCLONAL-ANTIBODY; ANTITUMOR-ACTIVITY; AUTOCRINE LOOP; COLON-CANCER; VIVO; EXPRESSION; ACTIVATION; CARCINOMA; insulin-like growth factor-I receptor; IGF-binding-protein-3; VEGF; STAT3; angiogenesis; pancreatic cancer
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Chirurgie
Medicine > Lehrstuhl für Pathologie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 28 Oct 2020 09:43
Last Modified: 28 Oct 2020 09:43
URI: https://pred.uni-regensburg.de/id/eprint/30653

Actions (login required)

View Item View Item